213 related articles for article (PubMed ID: 8228801)
21. Regulatory effects of IL-4 on human B-cell response to IL-2.
Galanaud P; Karray S; Llorente L
Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
[TBL] [Abstract][Full Text] [Related]
22. Analysis of high and low responses to Staphylococcus aureus and interleukin 2 in human B lymphocytes.
Peckham DW; Mower DA; Ashman RF
J Clin Immunol; 1993 Nov; 13(6):424-38. PubMed ID: 8288726
[TBL] [Abstract][Full Text] [Related]
23. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.
Armitage RJ; Macduff BM; Spriggs MK; Fanslow WC
J Immunol; 1993 May; 150(9):3671-80. PubMed ID: 8097223
[TBL] [Abstract][Full Text] [Related]
24. IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma.
Thyphronitis G; Tsokos GC; June CH; Levine AD; Finkelman FD
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5580-4. PubMed ID: 2546158
[TBL] [Abstract][Full Text] [Related]
25. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
26. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4.
van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE
J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306
[TBL] [Abstract][Full Text] [Related]
27. Structure/function analyses of IL-2 binding proteins on human B cell precursor acute lymphoblastic leukemias.
Wörmann B; Anderson JM; Ling ZD; LeBien TW
Leukemia; 1987 Sep; 1(9):660-6. PubMed ID: 3118114
[TBL] [Abstract][Full Text] [Related]
28. Proliferation of B cells from chronic lymphocytic leukemia is selectively promoted by B cell growth factor.
Alvarez-Mon M; de la Hera A; Gaspar ML; Orfao A; Casas J; Jordá J; Durantez A
Acta Haematol; 1989; 81(2):91-7. PubMed ID: 2496557
[TBL] [Abstract][Full Text] [Related]
29. Modalities of in vitro IgM and IgG production by peripheral blood lymphocytes of chronic lymphocytic leukemia patients and healthy volunteers.
Poljak LJ; Simaga S; Jaksic B; Vitale B
Leuk Lymphoma; 1993 Mar; 9(4-5):357-64. PubMed ID: 8348071
[TBL] [Abstract][Full Text] [Related]
30. Effect of interleukin-10 on anti-CD40- and interleukin-4-induced immunoglobulin E production by human lymphocytes.
Uejima Y; Takahashi K; Komoriya K; Kurozumi S; Ochs HD
Int Arch Allergy Immunol; 1996 Jul; 110(3):225-32. PubMed ID: 8688668
[TBL] [Abstract][Full Text] [Related]
31. The response of human B cells to interleukin 4 is determined by their stage of activation and differentiation.
Maher DW; Pike BL; Boyd AW
Scand J Immunol; 1990 Dec; 32(6):631-40. PubMed ID: 1702898
[TBL] [Abstract][Full Text] [Related]
32. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
[TBL] [Abstract][Full Text] [Related]
33. The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium.
Dechanet J; Merville P; Durand I; Banchereau J; Miossec P
J Clin Invest; 1995 Feb; 95(2):456-63. PubMed ID: 7532184
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency.
Borte S; Pan-Hammarström Q; Liu C; Sack U; Borte M; Wagner U; Graf D; Hammarström L
Blood; 2009 Nov; 114(19):4089-98. PubMed ID: 19738033
[TBL] [Abstract][Full Text] [Related]
35. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
[TBL] [Abstract][Full Text] [Related]
36. Anti-immunoglobulin and anti-CD40 stimulation induces CD25 expression by resting human tonsillar B lymphocytes.
Burlinson EL; Pringle HM; Ozanne BW; Cushley W
Immunol Lett; 1995 Feb; 45(1-2):93-8. PubMed ID: 7542628
[TBL] [Abstract][Full Text] [Related]
37. Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts.
Karasuyama H; Rolink A; Melchers F
J Exp Med; 1988 Apr; 167(4):1377-90. PubMed ID: 3128631
[TBL] [Abstract][Full Text] [Related]
38. RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells.
Kimata H; Yoshida A; Ishioka C; Fujimoto M; Lindley I; Furusho K
J Exp Med; 1996 May; 183(5):2397-402. PubMed ID: 8642352
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.
Rousset F; Garcia E; Defrance T; Péronne C; Vezzio N; Hsu DH; Kastelein R; Moore KW; Banchereau J
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1890-3. PubMed ID: 1371884
[TBL] [Abstract][Full Text] [Related]
40. Regulation of B-cell immune responses: predominant role of interleukin-4 in triggering cell proliferation and Ig production in competent B cells.
Or R; Renz H; Terada N; Gelfand EW
Clin Immunol Immunopathol; 1994 Jul; 72(1):141-9. PubMed ID: 8020187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
